Ultragenyx Pharmaceutical (RARE) Gross Profit Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -3.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.64% |
| Dec 31, 2025 | 20.65% |
| Sep 30, 2025 | 11.37% |
| Jun 30, 2025 | 14.11% |
| Mar 31, 2025 | 20.48% |
| Dec 31, 2024 | 27.91% |
| Sep 30, 2024 | 36.07% |
| Jun 30, 2024 | 27.80% |
| Mar 31, 2024 | 3.47% |
| Dec 31, 2023 | 17.62% |
| Sep 30, 2023 | 6.08% |
| Jun 30, 2023 | 21.37% |
| Mar 31, 2023 | 19.51% |
| Dec 31, 2022 | 22.72% |
| Sep 30, 2022 | 5.94% |
| Jun 30, 2022 | -3.30% |
| Mar 31, 2022 | -21.62% |
| Dec 31, 2021 | -7.18% |
| Sep 30, 2021 | -2.09% |
| Jun 30, 2021 | 39.95% |
| Mar 31, 2021 | 187.16% |
| Dec 31, 2020 | 182.30% |
| Sep 30, 2020 | 242.27% |
| Jun 30, 2020 | 156.19% |
| Mar 31, 2020 | 85.14% |
| Dec 31, 2019 | 93.51% |
| Sep 30, 2019 | 101.19% |
| Jun 30, 2019 | 84.80% |
| Mar 31, 2019 | 69.54% |